Objectives The authors report the procedural and 30-day results of the PASCAL
Transcatheter Valve Repair System (Edwards Lifesciences, Irvine, California) in patients …

Objectives The authors report the CLASP (Edwards PASCAL Transcatheter Mitral Valve
Repair System Study) expanded experience, 1-year outcomes, and analysis by functional …

Objectives This study reports 2-year outcomes from the multicenter, prospective, single-arm
CLASP study with functional mitral regurgitation (FMR) and degenerative MR (DMR) …

Background Severe symptomatic degenerative mitral regurgitation (DMR) has a poor
prognosis in the absence of treatment, and new transcatheter options are emerging …

Background Mitral valve transcatheter edge-to-edge repair is safe and effective in treating
degenerative mitral regurgitation (DMR) patients at prohibitive surgical risk, but outcomes in …

Background: Transcatheter mitral valve (MV) repair with the MitraClip received approval in
2013 for the treatment of prohibitive-risk patients with primary mitral regurgitation (MR) …

Background Severe mitral regurgitation is associated with impaired prognosis if left
untreated. Using the devices currently available, transcatheter mitral valve repair (TMVr) …

Background Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge
repair of severe mitral regurgitation, as compared with outcomes after maximal doses of …

Abstract Background: The EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy)
High-Risk registry and REALISM Continued Access Study High-Risk Arm are prospective …

Objectives: This study sought to evaluate 4-year outcomes of percutaneous repair versus
surgery for mitral regurgitation. Background: Transcatheter therapies are being developed to …